TherapeuticsMD Inc
Research TherapeuticsMD Inc (TXMD) on Bullrun: market cap USD 26.39M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTXMD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 26.39M
- Financial periodQ1 2026
- RevenueUSD 724.00K
- Net incomeUSD 95.00K
- Free cash flowUSD 2.70M
Valuation Snapshot
latest market cap is USD 26.39M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 3.02M | -USD 569.00K | USD 2.45M | n/a | -0.05 | USD 7.48M | USD 6.10M | USD 26.88M |
| FY2024 | USD 1.76M | -USD 2.18M | USD 1.17M | n/a | -0.19 | USD 5.06M | USD 7.18M | USD 27.37M |
| FY2023 | USD 1.30M | -USD 10.28M | -USD 23.08M | 100.0% | -0.99 | USD 4.33M | USD 8.01M | USD 29.29M |
| FY2022 | USD 69.96M | USD 112.00M | n/a | 98.0% | 11.96 | USD 49.32M | USD 187.20M | USD 35.14M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 26.39M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 18.87M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 9.92M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 23.79M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 52.92M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 154.76M | n/a | n/a | n/a |
About TherapeuticsMD Inc
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is TherapeuticsMD Inc's market cap?
TherapeuticsMD Inc's market capitalization is USD 26.39M.
What does TherapeuticsMD Inc do?
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited.